Propanc Biopharma, Inc.

US$1.77As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:PPCBHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (74.49%)
Div yield —
ROE (161.86%)
Biotechnology
Beta (5Y) 3.34
PE TTM —
TSR TTM (99.43%)
Mkt cap US$1.121M
ROIC (88.99%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.82
2.81%
(64.02%)
Hold 0|3|7|7|3
2Q26
3Q26
4Q26
1Q27
Earnings per share$
0.02
0.02
0.02
0.02
22.25%
8.54%
4.43%
(1.49%)
Revenue$M
0.052
0.051
0.052
0.053
3.12%
1.89%
1.72%
2.68%
Peers (US$1.121M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
1.030
0.086
0.070
EBIT/Intx
1.067
0.351
0.264
Own earn%
37.04
(4.28)
4.51
Sh yield%
35.46
38.69
39.30
Owners
Insiders/Inst%
4.71
70.45
Short interest%
1.58
SBC / revenue%
5.99
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
5
Op margin range%
15–19
$1 testx
0.1
Incr. ROIC%
17